The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 27, 2021

Filed:

Jan. 05, 2018
Applicant:

Adamas Pharmaceuticals, Inc., Emeryville, CA (US);

Inventors:

Jack Nguyen, Berkeley, CA (US);

David Chernoff, Sausalito, CA (US);

Sangita Ghosh, Foster City, CA (US);

Gregory T. Went, Mill Valley, CA (US);

Timothy J. Fultz, Jasper, GA (US);

Assignee:

Adamas Pharmaceuticals, Inc., Emeryville, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 31/4015 (2006.01); A61K 9/00 (2006.01); A61K 31/19 (2006.01); A61K 31/192 (2006.01); A61P 25/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/165 (2013.01); A61K 9/0053 (2013.01); A61K 9/16 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5047 (2013.01); A61K 9/5078 (2013.01); A61K 31/19 (2013.01); A61K 31/192 (2013.01); A61K 31/4015 (2013.01); A61P 25/08 (2018.01); A61K 9/1635 (2013.01);
Abstract

Compositions and methods are provided for administering a pharmaceutical composition to a human patient. Compositions are administered to a human patient orally, once daily, at a therapeutically effective dose. The pharmaceutical compositions comprise a drug selected from the group consisting of brivaracetam, divalproex, lacosamide, levetiracetam, oxcarbazepine, vigabatrin, and pharmaceutically acceptable salts of any of the foregoing, and at least one excipient. At least one of said at least one excipients modifies the release of said drug to provide an extended release form. The pharmaceutical composition have pharmacokinetic properties recited in the claims.


Find Patent Forward Citations

Loading…